All times are stated in CET

OPENING PLENARY AND INTRODUCTION TO IPVC

Tuesday, July 21 | 18:00 – 19:45 | Hall A

Welcome by the meeting co-chair

Silvia De Sanjose, USA (PATH, Director of Scale-up Project Reproductive Health Global Program)

Welcome by the IPVS President and meeting co-chair

Margaret Stanley, UK (University of Cambridge, Department of Pathology, Emeritus Professor of Epithelial Biology)

Frontiers in modern Oncology in Spain

Luis Paz-Ares, Spain (Hospital Universitario Doce de Octubre, Medical Oncology department, Chief Physician)

Immunology

Rafi Ahmed, USA (Emory Vaccine Center, Director)

IPVC PLENARY SESSION 2

Wednesday, July 22 | 18:00 – 19:30 | Hall A

Global control of Hepatitis B

Pierre Van Damme, Belgium (University of Antwerp, Faculty of Medicine and Health Sciences, Professor)

HPV Pathogenesis in Animal Models

Paul Lambert, USA (Carbone Cancer Center, Director of the McArdle Laboratory for Cancer Research, Virology Program Leader)

Immunotherapy: Progress in the clinic

Cornelis Melief, The Netherlands (ISA Pharmaceuticals, Chief Scientific Officer; Leiden University Medical Center, Emeritus Professor and Head of the Department of Immunohematology and Blood Transfusion)

IPVC PLENARY SESSION 3

Thursday, July 23 | 18:00 – 19:30 | Hall A

T cell dysfunction and implications for immunotherapy

Andrea Schietinger, USA (Memorial Sloan Kettering Cancer Center, Assistant Professor and Cancer Immunologist)

Potential use of Nanoparticle therapy in HPV associated cancers and the potential role for precancer treatment

Howard Gendelman, USA (Durham Research Center, Professor of Internal Medicine and Infectious Diseases)

Methylation

Martin Widschwendter, UK (University College London, Head of the Department of Women’s Cancer)

IPVC PLENARY SESSION 4

Friday, July 24 | 11:00 – 12:35 | Hall A

Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer

Corey Casper, USA (Infectious Disease Research Institute, Interim President and Chief Scientific Officer)

Use of Deep Learning into Cervical Cancer Screening

Mark Schiffman, USA (National Cancer Institute, Senior Investigator)

Oral Cancer Therapeutics

Robert Ferris, USA (UPMC Hillman Cancer Center, Director)

IPVC CLOSING PLENARY

Friday, July 24 | 18:00 – 19:30 | Hall A

Immunology HPV vaccines

Denise Galloway, USA (Fred Hutch; Pathogen-Associated Malignancies Integrated Research Center, Scientific Director)

WHO’s Cervical Cancer Elimination Strategy

Princess Nothemba Simelela, Switzerland (Assistant Director-General/Special Adviser to DG, Strategic Programmatic Priorities)

Video message from WHO Director-General Tedros Adhanom Ghebreyesus

HPV, a personal view

Xavier Bosch, Spain (Catalan Institute of Oncology (ICO), Honorary Consultant to the Cancer Epidemiology Research Program & Director of the e-oncologia at ICO)

IPVC 2021

Ann Burchell, Canada (Dept of Family and Community Medicine and MAP Centre for Urban Health Solutions, St Michael’s Hospital, Associate Professor) & Eduardo Franco, Canada (Department of Oncology, McGill University, Professor and Chair)